Celldex Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Celldex Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2010 to 2023.
  • Celldex Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $7.64M, a 46.4% increase year-over-year.
  • Celldex Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $29.2M, a 57.2% increase year-over-year.
  • Celldex Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $23.9M, a 53% increase from 2022.
  • Celldex Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $15.6M, a 74.4% increase from 2021.
  • Celldex Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $8.95M, a 129% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $23.9M +$8.28M +53% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-26
2022 $15.6M +$6.66M +74.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-26
2021 $8.95M +$5.04M +129% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-26
2020 $3.92M -$636K -14% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $4.55M -$3.53M -43.7% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 $8.08M -$4.23M -34.4% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-29
2017 $12.3M -$3.01M -19.6% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-26
2016 $15.3M +$2.54M +19.9% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-07
2015 $12.8M +$5.92M +86.4% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-07
2014 $6.85M +$2.3M +50.7% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-14
2013 $4.55M +$2.25M +97.9% Jan 1, 2013 Dec 31, 2013 10-K/A 2016-02-25
2012 $2.3M -$44K -1.88% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-24
2011 $2.34M -$460K -16.4% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-03
2010 $2.8M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.